Interest groups and party politics often compromise policymaking. We bring objectivity to complex issues — for the good of all.

The Center for Evidence-based Policy’s unique approach helps our partners truly base their decisions on high-quality evidence, backed by a transparent and open process. Our work also helps policymakers meet annual budgeting challenges, better manage policy-related risks and support policy decisions before their organizations and their constituents.

icon

The Center’s team continually develops and revises our methods, which are centered around three major areas:

Evidence

Through the Drug Effectiveness Review Program (DERP), Medicaid Evidence-based Decisions Project (MED) and other programs, the Center produces more than 150 pieces of proprietary research evidence annually for state-level policymakers, summarizing the evidence and effectiveness of interventions designed to improve the health of the people they serve.

DERP, a 12-state collaborative between Medicaid and public pharmacy programs, offers the best available clinical evidence to inform policy decisions on pharmaceuticals. Our MED effort is a collaboration of 19 state agencies’ Medicaid programs using evidence to improve health through unbiased analysis. Contact us to learn more about participating.

Stakeholder Engagement

Even the best policies need stakeholder support to succeed. By engaging deeply with policy leaders, decision-makers, influencers and consumers, we gather diverse, relevant perspectives to achieve broad stakeholder buy-in and transparent decision-making — a powerful formula for well-informed, appropriate and actionable plans.

In New Hampshire, for example, the Center prepared a stakeholder-focused approach, rooted in strong evidence, that’s guiding the state’s ambitious agenda for health transformation, including practice change, payment reform and new cross-sector partnerships.

Policy Design

The Center works with state officials to develop real-world policies that incorporate evidence and focus squarely on outcomes and cost effectiveness. Our solutions are designed to fit the realities, as well as the unique culture, of where policies will be implemented. Through a generous investment by the Laura and John Arnold Foundation, the Center has launched SMART-D, tackling the challenge of high-cost drugs in Medicaid through alternative payment methods to improve patient access to effective therapies while allowing states to predict and manage costs.

Are we a good resource for your needs and challenges? Talk to us. We’re here to help.